The assessment of urinary Galectin-3 Binding Protein (G3BP)/creatinine ratio as a biomarker for lupus nephritis in Egyptian patients

Key Points

• Urinary galectin-3 binding protein/creatinine ratio shows potential as a biomarker for lupus nephritis.
• Evidence suggests that elevated levels correlate with disease activity in Egyptian patients.
• Assessment using urinary ratios provides a non-invasive approach to monitoring kidney inflammation.
• Highlights the need for further validation to establish reliability in diverse populations.